NCT05380557View on ClinicalTrials.gov

ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

TerminatedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

September 6, 2022

Study Completion Date

September 6, 2022

Conditions
Pancreatic AdenocarcinomaPancreatic CancerResectable Pancreatic Cancer
Interventions
DIAGNOSTIC_TEST

Germline genetic testing

Germline genetic testing will be provided to each patient

Trial Locations (1)

94103

Invitae SF, San Francisco

Sponsors
All Listed Sponsors
collaborator

Eastern Cooperative Oncology Group

NETWORK

lead

Invitae Corporation

INDUSTRY

NCT05380557 - ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing | Biotech Hunter | Biotech Hunter